| Literature DB >> 26761369 |
Felipe Gonçalves Dos Santos de Sá1, Ana Paula Lima-Leopoldo1, Bruno Barcellos Jacobsen1, Artur Junio Togneri Ferron1, Wagner Muller Estevam1, Dijon Henrique Salomé Campos2, Edson Castardeli1, Márcia Regina Holanda da Cunha1, Antonio Carlos Cicogna2, André Soares Leopoldo1.
Abstract
BACKGROUND: Diet-induced obesity is frequently used to demonstrate cardiac dysfunction. However, some rats, like humans, are susceptible to developing an obesity phenotype, whereas others are resistant to that.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26761369 PMCID: PMC4693663 DOI: 10.5935/abc.20150134
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Characteristics of the experimental groups
|
|
| ||
|---|---|---|---|
|
|
|
| |
| IBW (g) | 150 ± 12 | 152 ± 11 | 152 ± 10 |
| FBW (g) | 486 ± 34 | 545 ± 46 | 492 ± 41 |
| Weight gain (g) | 336 ± 31 | 393 ± 44 | 340 ± 40 |
| Epididymal fat (g) | 7.33 ± 1.72 | 12.9 ± 3.7 | 7.31 ± 1.94 |
| Retroperitoneal fat (g) | 8.74 ± 2.09 | 17.8 ± 6.2 | 9.84 ± 2.58 |
| Visceral fat (g) | 5.95 ± 1.34 | 10.6 ± 3.7 | 6.00 ± 1.21 |
| Body fat (g) | 22.2 ± 4.1 | 41.3 ± 12.8 | 23.1 ± 4.3 |
| Adiposity index (%) | 4.51 ± 0.73 | 7.53 ± 1.99 | 4.69 ± 0.67 |
| FC (g/day) | 26.6 ± 1.9 | 22.4 ± 2.8 | 20.8 ± 3.0 |
| CI (kcal/day) | 78.4 ± 5.7 | 81.6 ± 10.1 | 75.9 ± 10.9 |
| FE (%) | 2.40 ± 0.24 | 2.85 ± 0.50 | 2.59 ± 0.48 |
Values are expressed as mean ± standard deviation; n: Number of animals; C: Control; OP: Obesity prone; OR: Obesity resistant; IBW: Initial body weight; FBW: Final body weight; FC: Food consumption; CI: Calorie intake; FE: Feed efficiency;
C versus OP; p < 0.05;
C versus OR; p < 0.05;
OP versus OR, p < 0.05; One-way ANOVA for independent samples and Tukey's post hoc test.
Figure 1Hormonal profiles and comorbidities; n= number of animals. A: Serum glucose; B: Serum insulin; C: Blood glucose levels following an oral glucose load; D: Homeostasis model assessment of insulin resistance (HOMA-IR) in control (C, white circles; n = 34), obesity-prone (OP, black squares; n = 31) and obesity-resistant (OR, white triangles; n = 13) rats. Values are expressed as mean ± standard deviation. *C versus OP; p < 0.05.
Systolic blood pressure, and biochemical and hormonal profiles
|
| |||
|---|---|---|---|
|
|
|
|
|
| AUC (mg/dL/min) | 19823±4166 | 23718 ± 4172 | 21713±3887 |
| SBP (mmHg) | 128 ± 8 | 132 ± 11 | 131 ± 11 |
| Cholesterol (mg/dL) | 59.8 ± 14.0 | 67.2 ± 14.0 | 63.7 ± 9.1 |
| Triglycerides (mg/dL) | 54.6 ± 14.0 | 74.0 ± 26.2 | 62.4 ± 25.7 |
| HDL (mg/dL) | 36.2 ± 22.0 | 38.9 ± 19.5 | 40.5 ± 19.3 |
| LDL (mg/dL) | 25.5 ± 10.1 | 28.4 ± 13.4 | 27.6 ± 14.1 |
| Leptin (ng/mL) | 3.45 ± 5.47 | 6.70 ± 14.30 | 3.25 ± 4.66 |
Values are expressed as mean ± standard deviation; n: Number of animals; C: Control; OP: Obesity prone; OR: Obesity resistant; AUC: Area under the curve for glucose; SBP: Systolic blood pressure; HDL: High-density lipoprotein cholesterol; LDL: Low-density lipoprotein cholesterol;
Values are expressed as median ± semi-interquartile range;
C versus OP; p < 0.05;
OP versus OR, p < 0.05; One-wayANOVA for independent samples and Tukey's post hoc test; §Kruskal-Wallis one-way ANOVA and Dunn's post hoc test.
Figure 2Morphologic profiles of controls (C, n = 39), obesity-prone (OP, n = 35) and obesity-resistant (OR, n = 19) rats; n = Number of animals. A: Heart weight; B: Left ventricular (LV) weight; C: Right ventricular (RV) weight; D: Heart weight/tibial length; E: LV/tibial length: F: RV/tibial length. Values are expressed as mean ± standard deviation. *C versus OP; p < 0.05; #OP versus OR, p < 0.05.
Baseline data from isolated muscle preparations
|
|
| ||
|---|---|---|---|
|
|
|
| |
| DT (g/mm2) | 6.77 ± 1.68 | 6.10 ± 1.68 | 6.30 ± 1.37 |
| RT (g/mm2) | 1.22 ± 0.44 | 1.03 ± 0.38 | 0.99 ± 0.27 |
| +dT/dt (g/mm2/s) | 75.9 ± 18.8 | 70.6 ± 19.2 | 72.5 ± 16.2 |
| -dT/dt (g/mm2/s) | 25.3 ± 5.3 | 24.9 ± 7.0 | 24.0 ± 5.2 |
| CSA (mm2) | 1.10 ± 0.25 | 1.14 ± 0.29 | 1.10 ± 0.35 |
Values are expressed as mean ± standard deviation; n: Number of animals; C: Control; OP: Obesity prone; OR: Obesity resistant Baseline condition 2.5 mM [Ca2+]; DT Maximum developed tension normalized per cross-sectional area of the papillary muscle; RT: Resting tension normalized per cross-sectional area of the papillary muscle; Peak of the positive (+dT/dt) and negative (-dT/dt) tension derivatives normalized per cross-sectional area of the papillary muscle; CSA: Cross-sectional area; One-way ANOVA for independent samples and Tukey's post hoc test.
Figure 3Effects of post-rest contraction (PRC; A, B, and C) and increasing extracellular Ca2+ concentration (D, E, and F) in papillary muscles of control (C; n= 36), obesity-prone (OP; n = 35), and obesity-resistant (OR; n= 18) rats. PRC basal: 0.5 mM [Ca2+]. Values are expressed as mean ± standard deviation; n = number of animals. DT: maximum developed tension; Peak of the positive (+dT/dt) and negative (-dT/dt) tension derivatives. *C versus OP; p < 0.05; &C versus OR; p < 0.05.